Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.
作者信息
Cummings Jeffrey L
机构信息
Mary S. Easton Center for Alzheimer's Disease Research at UCLA, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
出版信息
Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015.
PMID:19328437
Abstract
摘要
相似文献
1
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.
Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015.
2
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.
Alzheimers Dement. 2009 Mar;5(2):125-7. doi: 10.1016/j.jalz.2009.01.005.
3
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007.
4
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004.
5
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006.
6
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023.
7
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021.
8
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.
Alzheimers Dement. 2009 Mar;5(2):157-8. doi: 10.1016/j.jalz.2009.01.009.
9
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
Alzheimers Dement. 2009 Mar;5(2):149-53. doi: 10.1016/j.jalz.2009.01.012.
10
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.
Alzheimers Dement. 2009 Mar;5(2):128-9. doi: 10.1016/j.jalz.2009.01.018.
引用本文的文献
1
Integrating ADNI results into Alzheimer's disease drug development programs.
Neurobiol Aging. 2010 Aug;31(8):1481-92. doi: 10.1016/j.neurobiolaging.2010.03.016. Epub 2010 May 5.
2
Current treatment and recent clinical research in Alzheimer's disease.
Mt Sinai J Med. 2010 Jan-Feb;77(1):3-16. doi: 10.1002/msj.20165.
Zotero 插件